|
KMID : 0613820140240010098
|
|
Journal of Life Science
2014 Volume.24 No. 1 p.98 ~ p.103
|
|
|
NAD(P)H Quinone Oxidoreductase 1 (NQO1) as a Cancer Therapeutic Target
|
|
Park Eun-Jung
Kwon Taeg-Kyu
|
|
|
Abstract
|
|
|
|
NAD(P)H quinone oxidoreductase 1 (NQO1) is a flavoprotein that catalyzes the two electron reduction of diverse substrates, including quinones. It uses NADH or NADPH as a cofactor for enzymatic machinery. In the metabolism of quinones, NQO1 has two conflicting functions because of the different stability of converted hydroquinones. The stable form of hydroquinone is excreted from cells by conjugation with glutathione or glucuronic acid. The unstable form of hydroquinone induces cell death by induction of oxidative stress and DNA damage. Certain quinones known as bio-reductive agents have a cytotoxic function following reduction by NQO1. Bio-reductive agents, such as β-lapachone or mitomycin C, induce the depletion of NAD(P)H and the generation of oxidative stress in an NQO1-dependent manner. NQO1 is highly expressed in several cancer tissues. Therefore, NQO1 is a good therapeutic target for cancer treatment with bio-reductive agents.
|
|
|
KEYWORD
|
|
|
Cancer, cell death, NAD(P)H Quinone Oxidoreductase 1 (NQO1), oxidative stress, β-lapachone
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|